Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35.0Revenue (TTM) $M0.7Net Margin (%)-3,799.2Altman Z-Score-14.2
Enterprise Value $M14.3EPS (TTM) $9.3Operating Margin %-4,499.0Piotroski F-Score4
P/E(ttm)0.3Beneish M-Score-2.5Pre-tax Margin (%)-3,802.9Higher ROA y-yY
Price/Book9.310-y EBITDA Growth Rate %-12.1Quick Ratio4.0Cash flow > EarningsN
Price/Sales33.15-y EBITDA Growth Rate %-34.9Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-62.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-211.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M11.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AEZS is held by these investors:



AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JürgenDirector 2014-11-12Buy600$60-95view
Ernst, JürgenDirector 2014-11-12Buy394$61.79-95.14view
Ernst, JürgenDirector 2014-11-12Buy76$61.49-95.12view
Ernst, JürgenDirector 2014-11-12Buy31$61.4-95.11view
Ernst, JürgenDirector 2014-11-12Buy149$61.46-95.12view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy85$56.5-94.69view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy10$56.97-94.73view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy344$57-94.74view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy30$57.5-94.78view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy1,281$58-94.83view

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    Aeterna Zentaris Announces Zoptrex™ Presentation in Prostate Cancer at 2017 Genitourinary Cancers... Feb 14 2017
    Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™ Feb 13 2017
    Aeterna Zentaris to Present at the 2nd Annual Disruptive Growth & Healthcare Conference Feb 09 2017
    Aeterna Zentaris to Present at the 2017 BIO CEO and Investor Conference Feb 07 2017
    Drug Approvals Expected to Rise as Trump Pledges to Speed Up Approval Process: Latest Reports on... Feb 01 2017
    Expectations Run High At AEterna Zentaris Inc. (USA) (AEZS) As Two New Drugs Enter Final Testing... Jan 31 2017
    Aeterna Zentaris Announces Completion of Zoptrex™ Pivotal Phase 3 Clinical Trial in Advanced... Jan 30 2017
    Biotech Industry Outperforming Markets in 2017: Latest Reports on Pulmatrix and Aeterna Zentaris Jan 18 2017
    Dryships, Agile Therapeutics in Thursday’s 52-Week Low Club Jan 05 2017
    AEterna Zentaris Inc. (USA) (AEZS) Is Down, But Probably Not Out Jan 05 2017
    01.04.2017 Aeterna Zentaris Announces Top-Line Results of Confirmatory Phase 3 Trial of Macrilen™ Jan 04 2017
    Aeterna Zentaris Announces Top-Line Results of Confirmatory Phase 3 Trial of Macrilen™ Jan 04 2017
    Æterna Zentaris, Inc. :AEZS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016 Nov 15 2016
    Aeterna Zentaris 3Q Loss $6M or 61c/Share (AEZS) Nov 09 2016
    AEterna Zentaris Inc. (USA) (AEZS) Lines Up A Binary Event Reversal For The First Quarter Nov 09 2016
    11.08.2016 Aeterna Zentaris Reports Third Quarter 2016 Financial and Operating Results Nov 08 2016
    Aeterna Zentaris Reports Third Quarter 2016 Financial and Operating Results Nov 08 2016
    11.01.2016 Aeterna Zentaris Announces Closing of US$7,560,000 Registered Direct Offering of Common... Nov 01 2016
    Aeterna Zentaris Announces Closing of US$7,560,000 Registered Direct Offering of Common Shares and... Nov 01 2016
    Here Are Three Big Biotech Movers And Our Take On What’s Next Oct 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)